STARTUP PROFILE

Clarity

COUNTRY
USA
FOUNDED
2022
CATEGORY
Neuromodulation
Developing a non-invasive headset using 40 Hz light and sound stimulation to restore brain rhythms in Alzheimer’s and related disorders
Visit website →
Market Notes · Biweekly

Track this company

Funding, launches and regulatory moves across the neurotech startup map.

Subscribed. Check your inbox to confirm.

•
Neurofounders Insights
$   Funding   -
Series A
MODALITY
Light/sound
FORM FACTOR
Headset/cap
INTERFACE DEPTH
Non-invasive
INDICATION
Dementia/impairment
TARGET USER
Patients
REGULATORY STAGE
Investigational
Clarity operates in the growing gamma-stimulation segment for Alzheimer’s, using 40 Hz audiovisual entrainment to target disease-modifying pathways. It sits alongside Cognito Therapeutics but remains earlier-stage, with differentiation primarily around device design and delivery rather than underlying biological mechanism.
•
Mentioned in Market Notes
MOST RECENT COVERAGE
#
10
Neurotech Has Arrived
15 September – 29 September 2026

Clarity published early feasibility results for its VR-based sensory stimulation platform in 11 people with mild cognitive impairment or mild Alzheimer's disease. The system embeds 40 Hz audiovisual stimulation, studied for its ability to entrain gamma brain rhythms, within immersive VR environments and cognitive tasks. In a single session, active stimulation produced significantly stronger neural responses than sham, alongside an exploratory improvement in memory.

Articles featuring
Clarity